George Medicines is not a traditional drug development company. We take existing, best-in-class treatments and formulate them into single pill, multi-mechanism combinations. These are intended to provide the optimal balance of high efficacy and improved safety, with potential for significant improvements in clinical outcomes and long-term adherence to treatment.
Single-pill combinations for non-communicable diseases
George Medicines’ drug development programmes target non-communicable diseases (NCDs), the world’s leading causes of death and disability. Our innovative, single-pill, multi-mechanism combinations, in novel and unique dosage strengths, would reduce the need for patients to take multiple sets of pills daily and offer the potential for improvements in medication adherence.
Affordability & Accessibility
By designing treatment combinations in a single pill, George Medicines is looking to make a socio-economic impact on patients’ lives as well as helping them to live better and longer. We strive to make better treatments for all.
Our partners know the local markets and populations well, enabling our medicines to reach the patients who need them in the most affordable way.